Reported Reactions

Devices › Pump, infusion

Device brand name · 80frn

Symbiq Dual Channel: medical device reports filed with FDA

1,103 reports name it, 2009–2015. Manufacturer given most often on reports: Hospira Costa Rica. Product code FRN.

1,103
device reports naming the brand
0% of all MAUDE reports · about 66 a year
0
reports, 12 months to August 2026
0 in the 12 months before
96.6%
classified as malfunction
98.5% across the product code
0.1%
classified as death, as reported
1 reports · not verified by FDA

FDA's MAUDE database holds 1,103 reports that name the brand "Symbiq Dual Channel" (80frn), received between November 2009 and November 2015; the manufacturer given most often on reports is Hospira Costa Rica. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.6%), injury (2.8%) and other (0.3%); across all pump, infusion reports (product code FRN) death is recorded in 0.1% and malfunction in 98.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are device inoperable (43.3%), failure to sense (30.6%) and overheating of device (12%). The patient problems coded most often are no patient involvement, low blood pressure/ hypotension and therapeutic response, decreased. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Symbiq Dual Channel was received in the five years to August 2026; the latest was received in November 2015.

By year received

02204392009: 920092010: 9320102011: 4220112012: 18920122013: 23620132014: 43920142015: 952015

Event type and report source

Event type, as classified on the report

Death0.1%1
Injury2.8%31
Malfunction96.6%1,065
Other0.3%3
Not given0.3%3

Who filed the report

Manufacturer report100%1,103
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 1,831,109 reports carrying product code FRN. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device inoperablethe device could not be used47843.3%0.3%
Failure to sense33830.6%0.9%
Overheating of device13212%0%
Excess flow or over-infusion222%1.2%
Occlusion within devicethe device blocked201.8%0.6%
Insufficient flow or under infusion151.4%0.8%
Breakthe device broke141.3%8.5%
Failure to deliverthe device did not deliver the dose or item141.3%0.8%
Loss of powerthe device lost power131.2%0.1%
Device alarm system100.9%2.8%
No audible alarm100.9%0.2%
Bent90.8%0.1%
Device displays incorrect message80.7%9.3%
Failure to calibrate40.4%0.9%
Charred30.3%0%
Device slipped30.3%0%
Inaccurate delivery30.3%0.4%
Device operates differently than expectedthe device behaved unexpectedly20.2%0.9%
Free or unrestricted flow20.2%0.1%
Overdelivery20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement51246.4%
Low blood pressure/ hypotension242.2%
Therapeutic response, decreased30.3%
Bradycardiaslow heart rate20.2%
Cardiac arrestthe heart stopped20.2%
Hematuria20.2%
Apnea10.1%
Blood pressure, decreased10.1%
Cardiopulmonary arrest10.1%
Chemical exposure10.1%
Contamination, chemical10.1%
Deaththe patient died; cause not stated by this term10.1%
Electric shockan electric shock10.1%
Erythemaskin redness10.1%
Hyperglycemiahigh blood sugar10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSymbiq Dual ChannelProduct code FRNAll MAUDE reports
Reports1,1031,831,10926,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports119
Classified as injury2.8%1.3%36.2%
Classified as malfunction96.6%98.5%62.3%
Filed by the manufacturer100%99.1%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FRN

BrandReportsLatest 12 monthsClassified as death
Alaris Pump Module684,52200%
Alaris System422,50133,6920%
8100 Alaris Pump Module163,62000%
Spectrum Infusion Pump147,363150%
8015 Alaris System Pc Unit54,16200%
Alaris System Pc Unit24,06600%
8110 Alaris Syringe Pump22,43400%
Colleague21,76300%
Reservoir 3ML MMT-332A19,9142,0080.4%
Reservoir 3ml16,40700.8%
Flogard15,66800%
Colleague Volumetric Infusion Pump13,67800.1%
Colleague Pre P1 713,10300%
CADD-Solis VIP Ambulatory Infusion Pump11,7213,4710.1%
Intermate8,261470%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Symbiq Dual Channel reports

How many FDA reports name Symbiq Dual Channel?

1,103 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (96.6%), injury (2.8%) and other (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device inoperable (43.3%), failure to sense (30.6%), overheating of device (12%), excess flow or over-infusion (2%) and occlusion within device (1.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Symbiq Dual Channel was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.